After India jabs millions, its COVID-19 vaccine shows potency
Covaxin had been approved by government officials in January and administered to millions of people before it had been publicly proved to be safe or effective. Many people in India, including frontline health care workers, had feared Covaxin could be ineffective or worse, slowing down New Delhi ’s campaign to inoculate 1.3 billion people.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | COVID-19 | Government | Health Management | India Health | Pharmaceuticals | Vaccines